Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Purpose To investigate whether the blood-brain barrier (BBB) leaks blood-circulating substances in patients with early forms of Alzheimer disease (AD), and if so, to examine the extent and pattern of leakage. Materials and Methods This study was approved by the local medical ethical committees of the Maastricht University Medical Center and Leiden University Medical Center, and written informed consent was obtained from all subjects. For this pilot study, 16 patients with early AD and 17 healthy age-matched control subjects underwent dynamic contrast material–enhanced magnetic resonance (MR) imaging sequence with dual time resolution for 25 minutes. The Patlak graphical approach was used to quantify the BBB leakage rate and local blood plasma volume. Subsequent histogram analysis was used to determine the volume fraction of the leaking brain tissue. Differences were assessed with linear regression analysis, adjusted for confounding variables. Results The BBB leakage rate was significantly higher in patients compared with that in control subjects in the total gray matter (P < .05) and cortex (P = .03). Patients had a significantly higher volume fraction of the leaking brain tissue in the gray matter (P = .004), normal-appearing white matter (P < .04), deep gray matter (P = .01), and cortex (P = .004). When all subjects were considered, scores on the Mini-Mental State Examination decreased significantly with increasing leakage in the deep gray matter (P = .007) and cortex (P < .05). Conclusion The results of this study showed global BBB leakage in patients with early AD that is associated with cognitive decline. A compromised BBB may be part of a cascade of pathologic events that eventually lead to cognitive decline and dementia. ©RSNA, 2016 Online supplemental material is available for this article. An earlier incorrect version of this article appeared online. This article was corrected on October 24, 2016.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent neuroimaging studies in individuals with mild cognitive impairment (MCI) and early AD reveal BBB breakdown in the hippocampus, including its CA1 and dentate gyrus subfields (421), and several gray and white matter regions (220-222), respectively, before brain atrophy and dementia.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [220]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“BBB leakiness is seen both with normal ageing and AD [124,125].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [125]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the BBB disruption and increased permeability have been shown to occur in the early phase of the AD pathology (van de Haar et al., 2016).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as van de Haar et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Research works printed but not linked: 1
- Butman J, 2006, Proceedings of the Fourteenth Meeting of the International Society for Magnetic Resonance in Medicine, 1535
Cited by
Items 601–653 of 653
Verheggen, I. C. M., de Jong, J. J. A., van Boxtel, M. P. J., Postma, A. A., Verhey, F. R. J., Jansen, J. F. A., & Backes, W. H. (2020) · Figshare · doi:10.6084/m9.figshare.13161302
Self-citationYeapuri, P., Machhi, J., Lu, Y., Abdelmoaty, M. M., Kadry, R., Patel, M., Bhattarai, S., Lu, E., Namminga, K. L., Olson, K. E., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24864141
Verheggen, I. C. M., de Jong, J. J. A., van Boxtel, M. P. J., Postma, A. A., Verhey, F. R. J., Jansen, J. F. A., & Backes, W. H. (2020) · Figshare · doi:10.6084/m9.figshare.13161296
Self-citationJiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226961
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226973
Blood-brain barrier dysfunction as a physiological trigger of cellular senescence
Preininger, M. K. (2022) · eScholarship (California Digital Library)
Chupel, M. U. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
New experimental blood-brain barrier models for Alzheimer's disease studies
Niskanen, J. (2019) · UEF eRepo (University of Eastern Finland)
Presa, J. (2024) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Relationships between blood-brain barrier disruption and Alzheimer’s disease biomarkers in aging
Denkinger, M. N. (2024) · eScholarship (California Digital Library)
Impact of arterial stiffness on the development of Alzheimer's disease
Kahnouei, M. H. (2022) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/31276
Bourassa, P. (2020) · Corpus Université Laval (Université Laval)
Baker, S. K. (2020) · Digital Commons - RU (Rockefeller University) · doi:10.48496/jxem-0c74
The Effect of Psyllium (Plantago Ovata) Husk on Learning and Memory in Hypercholesteremic Rats
Fathy, M. M., Refaat, O. G., & Aborya, A. O. (2025) · مجلة الاقتصاد المنزلي · doi:10.21608/jhe.2025.468781
Araújo-Filho, I. (2025) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2025.60.009508
Alzate‐Correa, D., Stranan, J. P., Rincon‐Benavides, M. A., Mazo, N. A., Narváez-Pérez, L. F., Jaramillo-Garrido, S., Nguyen, T., Patel, R., Lawrence, W. R., Diaz‐Starokozheva, L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.22.700900
Chung, T. D., Liang, L. R., Wang, L., Kim, E. G., Gupta, S., Pandey, I., & Searson, P. C. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00773-x
Sobhan, R., Thrippleton, M. J., Willis, D., Gillings, R., Sami, S. A. K., Wardlaw, J. M., Minihane, A. M., Berry, N., & Cameron, D. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e44621
The Effects of Post-Translational Modifications on Repulsive Guidance Molecules
Mun, E. (2023) · TSpace (University of Toronto)
The bidirectional perspective between oral health and Alzheimer’s disease: integrative revision
Abaab, I. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Ketogenic diet impacts Blood-Brain Barrier physiology : implications for Alzheimers's disease
Corsi, M. (2018) · theses.fr (ABES) · doi:10.70675/36cd4c36z2faaz4535zaafdz8f54069c5015
Contribution de la voie Wnt dans la stabilité de la barrière hémato-encéphalique
Gueniot, F. (2019) · theses.fr (ABES) · doi:10.70675/7bb4438cz6983z40a4zb67bzd7cc0b7bb81c
Signatures épigénétiques de la maladie d'Alzheimer dans l'ADN libre circulant
Guemri, J. (2021) · theses.fr (ABES) · doi:10.70675/aa3cb199zc068z4b72zab7fz6deb0fe1de87
Blood-brain barrier permeability changes and neuroinflammation in Alzheimer disease progression
Keighley, D., & Raworth, T. (2025) · International Journal of Biology Sciences · doi:10.33545/26649926.2025.v7.i6g.778
Tsai, S., Liew, H., Wang, M.-J., Hung, W.-T., & Huang, H.-Y. (2026) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj-d-25-00173
Banjare, P., & Patel, R. (2026) · DNA repair · doi:10.1016/j.dnarep.2026.103940
Jernigan, J. E., Menees, K. B., & Tansey, M. G. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03858-4
Rundfeldt, H. C., Schellekens, W., Roefs, E. C. A., Bhogal, A. A., Báez‐Yáñez, M. G., Zwanenburg, J. J. M., & Petridou, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.730775
Wu, J., Sheng, J., Xiao, Y., Wu, F., He, P., Jiang, R., Zuo, Z., & Wang, P. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1843413
Zhang, C., Fang, D., & Zhang, L. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s619901
Serotonergic System Dysregulation in Alzheimer’s Disease
Al-Ghraiybah, N. F., Alkhalifa, A. E., Spivey, D., Averill, T., Engelkemier, B., Lopez, P. H., Stuckey, M. G., Jenkins, L., & Kaddoumi, A. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00236
Ahn, H., Gourrierec, T. L., Jung, Y., Kim, S., Hwang, S.-H., Park, J., Lee, D. Y., Sohn, C. H., & Park, S. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.122132
Cheng, J., Salian, V. S., Badola, M., & Kandimalla, K. K. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127353
How can we best utilize magnetic resonance for microbubble-mediated drug delivery to the brain
Huang, Y., & Hynynen, K. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2711975
Terribile, G., Pedrinazzi, M., Frigerio, I., Sancini, G., & Combi, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167165
ABLIM1 supports cerebrovascular endothelial barrier integrity in an IL-1β-treated hCMEC/D3 model
Zhang, X., Zheng, Q., Jiao, J., Su, C., Zhang, J., Li, Y., Guo, J., & Wang, R. (2026) · Scientific Reports · doi:10.1038/s41598-026-67176-8
Amplitude of physiological brain pulsations in Alzheimer’s diseasePreprint
Perkiömäki, V., Raitamaa, L., Mattila, H., Elabasy, A., Huotari, N., Väyrynen, T., Tuunanen, J., Helakari, H., Järvelä, M., Kananen, J., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9725762/v1
Zhijian, C., Haizhi, Z., Yihong, H., Weiyang, X., Jingjing, Z., Chen, Q., & Zheng, T. (2026) · European Journal of Radiology · doi:10.1016/j.ejrad.2026.113244
Abortive transcripts in exosomes - A potential biomarker for Alzheimer’s disease
Wu, H., Zhang, N., Yan, W., Li, C., Zhang, X., Xv, X., Fang, F., Qin, S., & Zhao, L. (2026) · PLoS ONE · doi:10.1371/journal.pone.0357752
Posttraumatic Stress Disorder, Health-Related Social Needs, and Cognitive Outcomes in US Veterans
Ouyang, F.-Y., Pogoda, T. K., Reisman, J., Li, R.-M., Pradhan, R., Moradi, Y., Mez, J., Liu, W., Zhang, Y.-F., Sultana, S., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.34839
Benhora-Chabeaux, G., MORISSET, C., NICOD, T., Mor, D., DELABROUILLE-CAULIEZ, S., Cabeza, L., Etiévant, A., & Bourasset, F. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02448-y
McCausland, B. M. S., Varatharaj, A., Huneke, N. T. M., Abraham, S., Abadalkareem, R., Thomas, B., Gee, C. L., Kunicki, A. P., Darekar, A., Teeling, J. L., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-71888-2
Li, J., Wang, Y., Liu, Y., 姬颖华, Lü, P., Yang, W., & Zhang, S. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109709
Tang, L., Zhou, Q., Seong, D., Nhan, L., Razansky, D., & Deán‐Ben, X. L. (2026) · Research Square · doi:10.21203/rs.3.rs-11333091/v1
Nwalema, N., & Thomas, S. A. (2026) · Frontiers in Drug Delivery · doi:10.3389/fddev.2026.1957314
Ford, J. N., Zhang, Q., Sweeney, E. M., Merkler, A. E., de Leon, M. J., Gupta, A., Nguyen, T. D., & Ivanidze, J. (2022) · doi:10.3389/fnagi.2022.867452.s001
Leaston, J., Qiao, J., Harding, I. C., Kulkarni, P., Gharagouzloo, C., Ebong, E., & Ferris, C. F. (2021) · doi:10.3389/fneur.2021.729464.s003
Supporting information 1 of Robust Multi-TE ASL-Based Blood–Brain Barrier Integrity Measurements
Mahroo, A., Buck, M. A., Huber, J., Breutigam, N.-J., Mutsaerts, H. J. M. M., Craig, M., Chappell, M., & Günther, M. (2021) · doi:10.3389/fnins.2021.719676.s001
Extracellular vesicles and their role in neurodegenerative diseases
Spiers, J. G., Broatch, J. R., & Hill, A. F. (2026) · Nature reviews. Neuroscience · doi:10.1038/s41583-026-01103-8
Metadata
- Authors
- van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H.
- Affiliations
- Maastricht University Medical Centre (NL)
- Leiden University Medical Center (NL)
- Leiden University (NL)
- ORCID
- Venue
- Radiology
- Published
- 2016-11
- Volume
- 281
- Issue
- 2
- Pages
- 527-535
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2415637550
- Cited by
- 601
- References
- 32
- Citations by year
- 2026: 37 · 2025: 56 · 2024: 66 · 2023: 65 · 2022: 81 · 2021: 89 · 2020: 64 · 2019: 50 · 2018: 42 · 2017: 36 · 2016: 13
- FWCI
- 25.63
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Radiology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Radiological Society of North America
- Internationale Stichting Alzheimer Onderzoek (10553)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- blood-brain barrier disruption, early Alzheimer's disease, dynamic contrast-enhanced MRI, Patlak graphical analysis, plasma volume, gray matter, normal-appearing white matter, deep gray matter, cognitive decline, Mini-Mental State Examination
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Blood Volume, Blood-Brain Barrier, Contrast Media, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Pilot Projects, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.